Tranquis Therapeutics is a breakthrough biopharmaceutical company focused on developing a portfolio of promising small molecule drugs with a unique mechanism of action, capable of reprogramming dysfunctional myeloid immune cells to revolutionize the management of a broad range of mitochondrial and immune mediated CNS and non-CNS indications and to significantly improve the lives of millions of patients. Founded on groundbreaking neuro-immunology research from the laboratory of Professor Edgar Engleman, MD, at Stanford University, Tranquis’ novel therapies work by restoring normal mitochondrial biogenesis, cell homeostasis and function, effectively “switching” microglia and monocytes from a dysfunctional to a functional state by targeting master regulators of cell energy metabolism. For more information, visit www.tranquis.com.
View Top Employees from Tranquis Therapeutics, Inc.Website | https://tranquis.com/ |
Revenue | $3 million |
Employees | 16 (16 on RocketReach) |
Founded | 2016 |
Address | 3 Lagoon Drive Suite 130, Redwood City, California 94065, US |
Phone | (650) 684-8950 |
Technologies |
JavaScript,
HTML,
PHP
+13 more
(view full list)
|
Industry | Biotechnology, Business Services General, Business Services |
Competitors | Cognition Therapeutics, Inc., Collaborative Medicinal Development LLC, Neuropore Therapies, Inc., Q Therapeutics, rPeptide |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies |
Looking for a particular Tranquis Therapeutics, Inc. employee's phone or email?
The Tranquis Therapeutics, Inc. annual revenue was $3 million in 2024.
16 people are employed at Tranquis Therapeutics, Inc..
Tranquis Therapeutics, Inc. is based in Redwood City, California.
The NAICS codes for Tranquis Therapeutics, Inc. are [54, 5417, 54171, 541714, 541].
The SIC codes for Tranquis Therapeutics, Inc. are [87, 873].